SBRT and Atezolizumab in the Management of Recurrent, Persistent, or Metastatic Cervical Cancer
Clinical trial NCT03614949 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03614949
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-29
- Primary completion
- 2028-10-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.